BeOne Medicines CEO sells ADSs for tax withholding
BeOne Medicines Ltd. Chief Executive Officer John Oyler reported tax-related transactions in American Depositary Shares (ADSs).
Rhea-AI Filing Summary
BeOne Medicines Ltd. Chief Executive Officer John Oyler reported tax-related transactions in American Depositary Shares (ADSs). On June 8, 2026, a total of 4,940 ADSs were sold at weighted average prices of about $270–$271 per ADS. A footnote explains the sale was carried out under a mandatory tax withholding provision connected to the vesting of a previously granted restricted share unit award, rather than a discretionary open-market sale. Each ADS represents 13 Ordinary Shares. Following these transactions, Oyler held no ADSs directly, but continued to have substantial Ordinary Share holdings directly and through various trusts and entities, some of which he disclaims beneficial ownership in the footnotes.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 4,940 shares
Net Sell
8 txns
Insider
OYLER JOHN
Role
Chief Executive Officer
Sold
4,940 shs ($1.34M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | American Depositary Shares | 3,820 | $270.3847 | $1.03M |
| Sale | American Depositary Shares | 1,120 | $271.1411 | $304K |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
American Depositary Shares — 0 shares (Direct);
Ordinary Shares — 5,545,055 shares (Direct);
Ordinary Shares — 46,031,994 shares (Indirect, See Footnote)
Footnotes (9)
- F1. These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.
- F2. These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- F3. These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- F4. These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
- F5. These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.
- F6. Each American Depositary Share represents 13 Ordinary Shares
- F7. The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon change of control or certain termination events.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.89 to $270.86, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.98 to $271.24, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
Key Figures
ADSs sold: 4,940 ADSs
ADS block sale 1: 3,820 ADSs at $270.3847
ADS block sale 2: 1,120 ADSs at $271.1411
+4 more
7 metrics
ADSs sold
4,940 ADSs
Total American Depositary Shares sold on June 8, 2026
ADS block sale 1
3,820 ADSs at $270.3847
Weighted average price for one sale block
ADS block sale 2
1,120 ADSs at $271.1411
Weighted average price for second sale block
ADS to Ordinary Share ratio
1 ADS = 13 Ordinary Shares
Economic equivalence disclosed in footnote
Direct Ordinary Shares
5,545,055 Ordinary Shares
Direct Ordinary Share holdings after transactions
Indirect Ordinary Shares example
28,204,115 Ordinary Shares
One indirect Ordinary Share holding balance with disclaimer
Holding entry example
102,188 Ordinary Shares
Indirect Ordinary Share balance in a trust
Key Terms
American Depositary Shares, grantor retained annuity trust, Roth IRA, mandatory tax withholding, +1 more
5 terms
grantor retained annuity trust financial
"These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
Roth IRA financial
"These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account"
A Roth IRA is a retirement savings account you fund with money that’s already been taxed, and withdrawals taken in retirement under the account rules are tax-free. It matters to investors because it shifts the tax bill to today instead of retirement, potentially increasing after-tax income later—think of it like paying for a lifetime subscription now so you can use it without extra charges in the future—helpful for long-term tax planning and flexibility.
mandatory tax withholding financial
"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did BeOne Medicines (ONC) report for its CEO?
BeOne Medicines CEO John Oyler reported selling 4,940 American Depositary Shares. The sale was executed to satisfy mandatory tax withholding obligations tied to vesting restricted share units, rather than as a discretionary open-market trade.
How many BeOne Medicines (ONC) ADSs did the CEO sell and at what prices?
John Oyler sold 4,940 American Depositary Shares in two blocks: 3,820 ADSs at a weighted average price of $270.3847 and 1,120 ADSs at $271.1411. Both blocks were reported as open-market sales on June 8, 2026.
Why were BeOne Medicines (ONC) ADSs sold by the CEO according to the filing?
The ADS sale was made under a mandatory tax withholding provision linked to a restricted share unit award. When the RSUs vested, shares were sold to cover associated tax obligations, rather than representing a voluntary reduction of the CEO’s investment position.
How do the CEO’s RSUs at BeOne Medicines (ONC) vest over time?
The restricted share unit award vests in four equal installments, with one-quarter vesting on each anniversary of June 5, 2024. Unvested RSUs may vest earlier upon a change of control or certain qualifying termination events, as described in the footnote.
AI-generated analysis. How Rhea-AI works. Not financial advice.
